{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:11:39Z","timestamp":1790097099526,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13048-014-0109-z","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T18:56:41Z","timestamp":1417719401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes"],"prefix":"10.1186","volume":"7","author":[{"given":"Ayala","family":"Tamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ushma","family":"Jag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreeja","family":"Sarojini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Schindewolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Gharbaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzeen","family":"Patwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Chirina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Oh Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Goy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pecora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Stephen","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,5]]},"reference":[{"issue":"8","key":"109_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1586\/erm.10.87","volume":"10","author":"KS Suh","year":"2010","unstructured":"Suh KS, Park SW, Castro A, Patel H, Blake P, Liang M, Goy A: Ovarian cancer biomarkers for molecular biosensors and translational medicine. Expert Rev Mol Diagn 2010,10(8):1069\u20131083. 10.1586\/erm.10.87","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"109_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","volume":"26","author":"CN Landen Jr","year":"2008","unstructured":"Landen CN Jr, Birrer MJ, Sood AK: Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008,26(6):995\u20131005. 10.1200\/JCO.2006.07.9970","journal-title":"J Clin Oncol"},{"key":"109_CR3","volume-title":"SEER Cancer Statistics Review 1975\u20132007","author":"SF Altekruse","year":"2010","unstructured":"Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK: SEER Cancer Statistics Review 1975\u20132007. National Cancer Institute, Bethesda, MD; 2010."},{"issue":"6","key":"109_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast RC Jr, Hennessy B, Mills GB: The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009,9(6):415\u2013428. 10.1038\/nrc2644","journal-title":"Nat Rev Cancer"},{"key":"109_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1757-2215-3-8","volume":"3","author":"JA Gubbels","year":"2010","unstructured":"Gubbels JA, Claussen N, Kapur AK, Connor JP, Patankar MS: The detection, treatment, and biology of epithelial ovarian cancer. J Ovarian Res 2010, 3: 8. 10.1186\/1757-2215-3-8","journal-title":"J Ovarian Res"},{"issue":"6","key":"109_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrclinonc.2010.44","volume":"7","author":"AK Karam","year":"2010","unstructured":"Karam AK, Karlan BY: Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol 2010,7(6):335\u2013339. 10.1038\/nrclinonc.2010.44","journal-title":"Nat Rev Clin Oncol"},{"key":"109_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4757-3587-1_3","volume":"107","author":"RC Bast Jr","year":"2002","unstructured":"Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G: Early detection of ovarian cancer: promise and reality. Cancer Treat Res 2002, 107: 61\u201397.","journal-title":"Cancer Treat Res"},{"issue":"3","key":"109_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/003655102317475434","volume":"62","author":"MK Tuxen","year":"2002","unstructured":"Tuxen MK, Soletormos G, Dombernowsky P: Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up. Scand J Clin Lab Invest 2002,62(3):177\u2013188. 10.1080\/003655102317475434","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"109_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jnci\/djp438","volume":"102","author":"GL Anderson","year":"2010","unstructured":"Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N, O'Briant K, Drescher C, Urban N: Assessing lead time of selected ovarian cancer biomarkers: a nested case\u2013control study. J Natl Cancer Inst 2010,102(1):26\u201338. 10.1093\/jnci\/djp438","journal-title":"J Natl Cancer Inst"},{"key":"109_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-0-387-68969-2_2","volume":"622","author":"I Hellstrom","year":"2008","unstructured":"Hellstrom I, Hellstrom KE: SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and\/or each other. Adv Exp Med Biol 2008, 622: 15\u201321. 10.1007\/978-0-387-68969-2_2","journal-title":"Adv Exp Med Biol"},{"issue":"13","key":"109_CR11","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1200\/JCO.2008.19.2484","volume":"28","author":"Z Yurkovetsky","year":"2010","unstructured":"Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC Jr, Lokshin AE: Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol 2010,28(13):2159\u20132166. 10.1200\/JCO.2008.19.2484","journal-title":"J Clin Oncol"},{"issue":"3","key":"109_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","volume":"117","author":"B Nolen","year":"2010","unstructured":"Nolen B, Velikokhatnaya L, Marrangoni A, De Geest K, Lomakin A, Bast RC Jr, Lokshin A: Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol 2010,117(3):440\u2013445. 10.1016\/j.ygyno.2010.02.005","journal-title":"Gynecol Oncol"},{"issue":"12","key":"109_CR13","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1055-9965.EPI-10-0580","volume":"19","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Chan DW: The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev 2010,19(12):2995\u20132999. 10.1158\/1055-9965.EPI-10-0580","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"109_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajog.2010.03.043","volume":"203","author":"RG Moore","year":"2010","unstructured":"Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, Kurman RJ, Bast RC, Skates SJ: Comparison of a novel multiple marker assay vs the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010,203(3):228. e221\u2013226 10.1016\/j.ajog.2010.03.043","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"109_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/17530059.2012.661711","volume":"6","author":"BM Nolen","year":"2012","unstructured":"Nolen BM, Lokshin AE: Multianalyte assay systems in the differential diagnosis of ovarian cancer. Expert Opin Med Diagn 2012,6(2):131\u2013138. 10.1517\/17530059.2012.661711","journal-title":"Expert Opin Med Diagn"},{"issue":"3","key":"109_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s13277-010-0032-x","volume":"31","author":"M Donach","year":"2010","unstructured":"Donach M, Yu Y, Artioli G, Banna G, Feng W, Bast RC Jr, Zhang Z, Nicoletto MO: Combined use of biomarkers for detection of ovarian cancer in high-risk women. Tumour Biol 2010,31(3):209\u2013215. 10.1007\/s13277-010-0032-x","journal-title":"Tumour Biol"},{"issue":"15 Pt 1","key":"109_CR17","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1158\/1078-0432.CCR-06-2224","volume":"13","author":"MW McIntosh","year":"2007","unstructured":"McIntosh MW, Liu Y, Drescher C, Urban N, Diamandis EP: Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. Clin Cancer Res 2007,13(15 Pt 1):4422\u20134428. 10.1158\/1078-0432.CCR-06-2224","journal-title":"Clin Cancer Res"},{"issue":"10","key":"109_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1373\/clinchem.2006.071456","volume":"52","author":"SJ Shan","year":"2006","unstructured":"Shan SJ, Scorilas A, Katsaros D, Rigault de la Longrais I, Massobrio M, Diamandis EP: Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. Clin Chem 2006,52(10):1879\u20131886. 10.1373\/clinchem.2006.071456","journal-title":"Clin Chem"},{"issue":"4","key":"109_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/IGC.0b013e31821283c3","volume":"21","author":"MA El Sherbini","year":"2011","unstructured":"El Sherbini MA, Sallam MM, Shaban EA, El-Shalakany AH: Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer. Int J Gynecol Cancer 2011,21(4):625\u2013632. 10.1097\/IGC.0b013e31821283c3","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"109_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1515\/bc.2010.036","volume":"391","author":"G Sotiropoulou","year":"2010","unstructured":"Sotiropoulou G, Pampalakis G: Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation. Biol Chem 2010,391(4):321\u2013331. 10.1515\/bc.2010.036","journal-title":"Biol Chem"},{"issue":"4","key":"109_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/er.2009-0034","volume":"31","author":"MG Lawrence","year":"2010","unstructured":"Lawrence MG, Lai J, Clements JA: Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev 2010,31(4):407\u2013446. 10.1210\/er.2009-0034","journal-title":"Endocr Rev"},{"issue":"3","key":"109_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.molonc.2007.09.003","volume":"1","author":"N Emami","year":"2007","unstructured":"Emami N, Diamandis EP: New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family. Mol Oncol 2007,1(3):269\u2013287. 10.1016\/j.molonc.2007.09.003","journal-title":"Mol Oncol"},{"issue":"2","key":"109_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2217\/fon.09.149","volume":"6","author":"K Mavridis","year":"2010","unstructured":"Mavridis K, Scorilas A: Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Future Oncol 2010,6(2):269\u2013285. 10.2217\/fon.09.149","journal-title":"Future Oncol"},{"issue":"9B","key":"109_CR24","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1111\/j.1582-4934.2009.00763.x","volume":"13","author":"HV Nathalie","year":"2009","unstructured":"Nathalie HV, Chris P, Serge G, Catherine C, Benjamin B, Claire B, Christelle P, Briollais L, Pascale R, Marie-Lise J, Yves C: High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis. J Cell Mol Med 2009,13(9B):4014\u20134022. 10.1111\/j.1582-4934.2009.00763.x","journal-title":"J Cell Mol Med"},{"issue":"19 Pt 1","key":"109_CR25","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1158\/1078-0432.CCR-05-0943","volume":"11","author":"H Nagahara","year":"2005","unstructured":"Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M: Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res 2005,11(19 Pt 1):6800\u20136806. 10.1158\/1078-0432.CCR-05-0943","journal-title":"Clin Cancer Res"},{"issue":"6","key":"109_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1515\/BC.2006.083","volume":"387","author":"M Paliouras","year":"2006","unstructured":"Paliouras M, Diamandis EP: The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006,387(6):643\u2013652. 10.1515\/BC.2006.083","journal-title":"Biol Chem"},{"issue":"1","key":"109_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molonc.2013.09.003","volume":"8","author":"H Shahinian","year":"2014","unstructured":"Shahinian H, Loessner D, Biniossek ML, Kizhakkedathu JN, Clements JA, Magdolen V, Schilling O: Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGF\u03b2-1 signaling in ovarian cancer cells. Mol Oncol 2014,8(1):68\u201382. 10.1016\/j.molonc.2013.09.003","journal-title":"Mol Oncol"},{"issue":"11","key":"109_CR28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1349-7006.2008.00942.x","volume":"99","author":"P Kountourakis","year":"2008","unstructured":"Kountourakis P, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA: Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). Cancer Sci 2008,99(11):2224\u20132229. 10.1111\/j.1349-7006.2008.00942.x","journal-title":"Cancer Sci"},{"issue":"5","key":"109_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/hsz-2011-0264","volume":"393","author":"L Seiz","year":"2012","unstructured":"Seiz L, Dorn J, Kotzsch M, Walch A, Grebenchtchikov NI, Gkazepis A, Schmalfeldt B, Kiechle M, Bayani J, Diamandis EP, Langer R, Sweep FC, Schmitt M, Magdolen V: Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients. Biol Chem 2012,393(5):391\u2013401. 10.1515\/hsz-2011-0264","journal-title":"Biol Chem"},{"key":"109_CR30","first-page":"190","volume":"9","author":"PD Karp","year":"2004","unstructured":"Karp PD, Paley S, Krieger CJ, Zhang P: An evidence ontology for use in pathway\/genome databases. Pac Symp Biocomput 2004, 9: 190\u2013201.","journal-title":"Pac Symp Biocomput"},{"issue":"1","key":"109_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1476-9255-10-25","volume":"10","author":"DS Son","year":"2013","unstructured":"Son DS, Kabir SM, Dong Y, Lee E, Adunyah SE: Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells. J Inflamm 2013,10(1):25. 10.1186\/1476-9255-10-25","journal-title":"J Inflamm"},{"issue":"11","key":"109_CR32","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.18632\/oncotarget.1947","volume":"5","author":"H Cho","year":"2014","unstructured":"Cho H, Shin HY, Kim S, Kim JS, Chung JY, Chung EJ, Chun KH, Hewitt SM, Kim JH: The role of S100A14 in epithelial ovarian tumors. Oncotarget 2014,5(11):3482\u20133496.","journal-title":"Oncotarget"},{"issue":"10","key":"109_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1593\/neo.07472","volume":"9","author":"ML Puiffe","year":"2007","unstructured":"Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin PN, Chevrette M, Provencher DM, Mes-Masson AM: Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 2007,9(10):820\u2013829. 10.1593\/neo.07472","journal-title":"Neoplasia"},{"issue":"6","key":"109_CR34","doi-asserted-by":"publisher","first-page":"e2425","DOI":"10.1371\/journal.pone.0002425","volume":"3","author":"VM Faca","year":"2008","unstructured":"Faca VM, Ventura AP, Fitzgibbon MP, Pereira-Faca SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM: Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One 2008,3(6):e2425. 10.1371\/journal.pone.0002425","journal-title":"PLoS One"},{"issue":"5","key":"109_CR35","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.bjc.6690765","volume":"81","author":"K Wiechen","year":"1999","unstructured":"Wiechen K, Karaaslan S, Turzynski A, Dietel M: Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells. Br J Cancer 1999,81(5):790\u2013795. 10.1038\/sj.bjc.6690765","journal-title":"Br J Cancer"},{"issue":"1","key":"109_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijc.2910250104","volume":"25","author":"J Zeuthen","year":"1980","unstructured":"Zeuthen J, Norgaard JO, Avner P, Fellous M, Wartiovaara J, Vaheri A, Rosen A, Giovanella BC: Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer 1980,25(1):19\u201332. 10.1002\/ijc.2910250104","journal-title":"Int J Cancer"},{"issue":"15","key":"109_CR37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/jnci\/91.15.1327","volume":"91","author":"MT Furlong","year":"1999","unstructured":"Furlong MT, Hough CD, Sherman-Baust CA, Pizer ES, Morin PJ: Evidence for the colonic origin of ovarian cancer cell line SW626. J Natl Cancer Inst 1999,91(15):1327\u20131328. 10.1093\/jnci\/91.15.1327","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"109_CR38","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","volume":"10","author":"TJ Shaw","year":"2004","unstructured":"Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC: Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther 2004,10(6):1032\u20131042. 10.1016\/j.ymthe.2004.08.013","journal-title":"Mol Ther"},{"issue":"9","key":"109_CR39","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.24886","volume":"126","author":"M Pasquet","year":"2010","unstructured":"Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B: Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 2010,126(9):2090\u20132101.","journal-title":"Int J Cancer"},{"issue":"10","key":"109_CR40","first-page":"4970","volume":"45","author":"J Benard","year":"1985","unstructured":"Benard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, Chiric E, Riou G: Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 1985,45(10):4970\u20134979.","journal-title":"Cancer Res"},{"issue":"8","key":"109_CR41","first-page":"3668","volume":"45","author":"RN Buick","year":"1985","unstructured":"Buick RN, Pullano R, Trent JM: Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985,45(8):3668\u20133676.","journal-title":"Cancer Res"},{"issue":"1","key":"109_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","volume":"127","author":"C Korch","year":"2012","unstructured":"Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, Jordan VC, Bradford AP: DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol 2012,127(1):241\u2013248. 10.1016\/j.ygyno.2012.06.017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"109_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/gyno.1993.1034","volume":"48","author":"C Fuchtner","year":"1993","unstructured":"Fuchtner C, Emma DA, Manetta A, Gamboa G, Bernstein R, Liao SY: Characterization of a human ovarian carcinoma cell line: UCI 101. Gynecol Oncol 1993,48(2):203\u2013209. 10.1006\/gyno.1993.1034","journal-title":"Gynecol Oncol"},{"issue":"3","key":"109_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1006\/gyno.1995.1239","volume":"58","author":"G Gamboa","year":"1995","unstructured":"Gamboa G, Carpenter PM, Podnos YD, Dorion G, Iravani L, Bolton D, Mascarello JT, Manetta A: Characterization and development of UCI 107, a primary human ovarian carcinoma cell line. Gynecol Oncol 1995,58(3):336\u2013343. 10.1006\/gyno.1995.1239","journal-title":"Gynecol Oncol"},{"issue":"7","key":"109_CR45","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","volume":"89","author":"AK Godwin","year":"1992","unstructured":"Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME: High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 1992,89(7):3070\u20133074. 10.1073\/pnas.89.7.3070","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"109_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ijc.2910560415","volume":"56","author":"TL Moser","year":"1994","unstructured":"Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC Jr, Stack MS: Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer 1994,56(4):552\u2013559. 10.1002\/ijc.2910560415","journal-title":"Int J Cancer"},{"issue":"1","key":"109_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ygyno.2006.07.023","volume":"104","author":"DR Scoles","year":"2007","unstructured":"Scoles DR, Pavelka J, Cass I, Tran H, Baldwin RL, Armstrong K, Karlan BY: Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT. Gynecol Oncol 2007,104(1):120\u2013128. 10.1016\/j.ygyno.2006.07.023","journal-title":"Gynecol Oncol"},{"issue":"20","key":"109_CR48","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.1073\/pnas.91.20.9495","volume":"91","author":"K Orth","year":"1994","unstructured":"Orth K, Hung J, Gazdar A, Bowcock A, Mathis JM, Sambrook J: Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA 1994,91(20):9495\u20139499. 10.1073\/pnas.91.20.9495","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"109_CR49","first-page":"649","volume":"34","author":"WS Baldwin","year":"1998","unstructured":"Baldwin WS, Curtis SW, Cauthen CA, Risinger JI, Korach KS, Barrett JC: BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro. In vitro cellular & developmental biology. Animal 1998,34(8):649\u2013654.","journal-title":"Animal"},{"issue":"3","key":"109_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ygyno.2007.05.005","volume":"106","author":"Y Bermudez","year":"2007","unstructured":"Bermudez Y, Yang H, Saunders BO, Cheng JQ, Nicosia SV, Kruk PA: VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecol Oncol 2007,106(3):526\u2013537. 10.1016\/j.ygyno.2007.05.005","journal-title":"Gynecol Oncol"},{"issue":"12","key":"109_CR51","doi-asserted-by":"publisher","first-page":"e82620","DOI":"10.1371\/journal.pone.0082620","volume":"8","author":"M Kwon","year":"2013","unstructured":"Kwon M, Lee SJ, Reddy S, Rybak Y, Adem A, Libutti SK: Down-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected]. PLoS One 2013,8(12):e82620. 10.1371\/journal.pone.0082620","journal-title":"PLoS One"},{"issue":"2","key":"109_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1593\/neo.07817","volume":"10","author":"RS Henkhaus","year":"2008","unstructured":"Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA: Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia 2008,10(2):140\u2013148. 10.1593\/neo.07817","journal-title":"Neoplasia"},{"issue":"2","key":"109_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/sj.bjc.6603556","volume":"96","author":"SJ Shan","year":"2007","unstructured":"Shan SJ, Scorilas A, Katsaros D, Diamandis EP: Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. Br J Cancer 2007,96(2):362\u2013372. 10.1038\/sj.bjc.6603556","journal-title":"Br J Cancer"},{"issue":"4","key":"109_CR54","first-page":"893","volume":"21","author":"K Hua","year":"2009","unstructured":"Hua K, Din J, Cao Q, Feng W, Zhang Y, Yao L, Huang Y, Zhao Y, Feng Y: Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep 2009,21(4):893\u2013898.","journal-title":"Oncol Rep"},{"issue":"17","key":"109_CR55","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1021\/bi6025006","volume":"46","author":"SI Blaber","year":"2007","unstructured":"Blaber SI, Yoon H, Scarisbrick IA, Juliano MA, Blaber M: The autolytic regulation of human kallikrein-related peptidase 6. Biochemistry 2007,46(17):5209\u20135217. 10.1021\/bi6025006","journal-title":"Biochemistry"},{"issue":"4","key":"109_CR56","first-page":"381","volume":"391","author":"K Oikonomopoulou","year":"2010","unstructured":"Oikonomopoulou K, Batruch I, Smith CR, Soosaipillai A, Diamandis EP, Hollenberg MD: Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid. Biol Chem 2010,391(4):381\u2013390.","journal-title":"Biol Chem"},{"issue":"11","key":"109_CR57","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1474","volume":"4","author":"CA Borgono","year":"2004","unstructured":"Borgono CA, Diamandis EP: The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004,4(11):876\u2013890. 10.1038\/nrc1474","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"109_CR58","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1515\/BC.2006.102","volume":"387","author":"P Prezas","year":"2006","unstructured":"Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Kruger A, Magdolen V: Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 2006,387(6):807\u2013811. 10.1515\/BC.2006.102","journal-title":"Biol Chem"},{"issue":"9","key":"109_CR59","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1515\/cclm-2013-0151","volume":"51","author":"E Bandiera","year":"2013","unstructured":"Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, Tassi R, Bignotti E, Todeschini P, Tognon G, Romagnolo C, Gion M, Sartori E, Maggino T, Pecorelli S, Ravaggi A: Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. Clin Chem Lab Med 2013,51(9):1815\u20131824. 10.1515\/cclm-2013-0151","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"109_CR60","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/sj.bjc.6605280","volume":"101","author":"NM White","year":"2009","unstructured":"White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Dore JJ: KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. Br J Cancer 2009,101(7):1107\u20131113. 10.1038\/sj.bjc.6605280","journal-title":"Br J Cancer"},{"issue":"2","key":"109_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0009-9120(02)00446-0","volume":"36","author":"LG Kyriakopoulou","year":"2003","unstructured":"Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP: Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin Biochem 2003,36(2):135\u2013143. 10.1016\/S0009-9120(02)00446-0","journal-title":"Clin Biochem"},{"issue":"8","key":"109_CR62","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1373\/clinchem.2007.088104","volume":"53","author":"JL Shaw","year":"2007","unstructured":"Shaw JL, Diamandis EP: Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007,53(8):1423\u20131432. 10.1373\/clinchem.2007.088104","journal-title":"Clin Chem"},{"issue":"7","key":"109_CR63","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1158\/0008-5472.CAN-09-3415","volume":"70","author":"Y Dong","year":"2010","unstructured":"Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA: Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 2010,70(7):2624\u20132633. 10.1158\/0008-5472.CAN-09-3415","journal-title":"Cancer Res"},{"issue":"1","key":"109_CR64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/hsz-2013-0172","volume":"395","author":"J Dorn","year":"2014","unstructured":"Dorn J, Gkazepis A, Kotzsch M, Kremer M, Propping C, Mayer K, Mengele K, Diamandis EP, Kiechle M, Magdolen V, Schmitt M: Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer. Biol Chem 2014,395(1):95\u2013107. 10.1515\/hsz-2013-0172","journal-title":"Biol Chem"},{"issue":"5","key":"109_CR65","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3727\/096504008786111383","volume":"17","author":"CK Bose","year":"2008","unstructured":"Bose CK: Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer. Oncol Res 2008,17(5):231\u2013238. 10.3727\/096504008786111383","journal-title":"Oncol Res"},{"issue":"1","key":"109_CR66","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1677\/joe.0.1700243","volume":"170","author":"AM Holland","year":"2001","unstructured":"Holland AM, Findlay JK, Clements JA: Kallikrein gene expression in the gonadotrophin-stimulated rat ovary. J Endocrinol 2001,170(1):243\u2013250. 10.1677\/joe.0.1700243","journal-title":"J Endocrinol"},{"issue":"4","key":"109_CR67","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10911-009-9160-6","volume":"14","author":"JD Graham","year":"2009","unstructured":"Graham JD, Mote PA, Salagame U, Balleine RL, Huschtscha LI, Clarke CL: Hormone-responsive model of primary human breast epithelium. J Mammary Gland Biol Neoplasia 2009,14(4):367\u2013379. 10.1007\/s10911-009-9160-6","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2 Pt 1","key":"109_CR68","first-page":"611","volume":"171","author":"C Langner","year":"2004","unstructured":"Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R: Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors. J Urol 2004,171(2 Pt 1):611\u2013614.","journal-title":"J Urol"},{"issue":"8","key":"109_CR69","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/1078-0432.CCR-04-1276","volume":"11","author":"R Kumar","year":"2005","unstructured":"Kumar R, Gururaj AE, Vadlamudi RK, Rayala SK: The clinical relevance of steroid hormone receptor corepressors. Clin Cancer Res 2005,11(8):2822\u20132831. 10.1158\/1078-0432.CCR-04-1276","journal-title":"Clin Cancer Res"},{"issue":"48","key":"109_CR70","doi-asserted-by":"publisher","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","volume":"284","author":"G Sotiropoulou","year":"2009","unstructured":"Sotiropoulou G, Pampalakis G, Diamandis EP: Functional roles of human kallikrein-related peptidases. J Biol Chem 2009,284(48):32989\u201332994. 10.1074\/jbc.R109.027946","journal-title":"J Biol Chem"},{"issue":"6","key":"109_CR71","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1515\/BC.2008.079","volume":"389","author":"A Eissa","year":"2008","unstructured":"Eissa A, Diamandis EP: Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions. Biol Chem 2008,389(6):669\u2013680. 10.1515\/BC.2008.079","journal-title":"Biol Chem"},{"issue":"2","key":"109_CR72","first-page":"161","volume":"27","author":"RA Soslow","year":"2008","unstructured":"Soslow RA: Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol 2008,27(2):161\u2013174.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"109_CR73","first-page":"897","volume":"20","author":"S Vukmirovic-Popovic","year":"2008","unstructured":"Vukmirovic-Popovic S, Escott NG, Duivenvoorden WC: Presence and enzymatic activity of prostate-specific antigen in archival prostate cancer samples. Oncol Rep 2008,20(4):897\u2013903.","journal-title":"Oncol Rep"},{"issue":"19","key":"109_CR74","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1002\/cncr.28183","volume":"119","author":"KH Lu","year":"2013","unstructured":"Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RC Jr: A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer 2013,119(19):3454\u20133461.","journal-title":"Cancer"},{"issue":"6","key":"109_CR75","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pmic.201100371","volume":"12","author":"U Kuzmanov","year":"2012","unstructured":"Kuzmanov U, Smith CR, Batruch I, Soosaipillai A, Diamandis A, Diamandis EP: Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry. Proteomics 2012,12(6):799\u2013809. 10.1002\/pmic.201100371","journal-title":"Proteomics"},{"issue":"1","key":"109_CR76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1373\/clinchem.2012.193060","volume":"59","author":"J Bayani","year":"2013","unstructured":"Bayani J, Kuzmanov U, Saraon P, Fung WA, Soosaipillai A, Squire JA, Diamandis EP: Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Clin Chem 2013,59(1):296\u2013305. 10.1373\/clinchem.2012.193060","journal-title":"Clin Chem"},{"issue":"5","key":"109_CR77","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","volume":"43","author":"WG McCluggage","year":"2011","unstructured":"McCluggage WG: Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 2011,43(5):420\u2013432. 10.1097\/PAT.0b013e328348a6e7","journal-title":"Pathology"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-014-0109-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-014-0109-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-014-0109-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-014-0109-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:32:19Z","timestamp":1717605139000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-014-0109-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":77,"aliases":["10.1186\/preaccept-1736656869122663"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1186\/s13048-014-0109-z","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"7 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"109"}}